CHOC joins NIH-funded study aimed to evaluate if home sleep studies can be used in children for behavioral sleep training and OSA treatment.
New clinic and study site for patients with rare syndrome Fragile X opens in Thompson Autism and Neurodevelopmental Center
The Fragile X Clinic at CHOC will be devoted to the diagnosis, treatment, and study of the rare genetic condition of Fragile X syndrome.
CHOC doctors led a study that helped garner authorization by the FDA of a digital diagnosis aid that will help to diagnose autism.
Gold’s creation, an app he calls uTine, is on the verge of being tested on patients at the Thompson Autism and Neurodevelopmental Center.
The Thompson Autism and Neurodevelopmental Center addresses autism defined core symptoms through a medical home approach that reduces unmet healthcare needs.
Dr. Tom Megerian, clinical director of the Thompson Autism and Neurodevelopmental Center at CHOC, discusses research suggesting children may outgrow autism.